Latest Cancer News

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (05-18-2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading

More Cancer News

Patient Resources